1. Home
  2. NIO vs CORT Comparison

NIO vs CORT Comparison

Compare NIO & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NIO Inc. American depositary shares each  representing one ordinary share

NIO

NIO Inc. American depositary shares each representing one ordinary share

HOLD

Current Price

$3.67

Market Cap

12.7B

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

SELL

Current Price

$113.79

Market Cap

9.7B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NIO
CORT
Founded
2014
1998
Country
China
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.7B
9.7B
IPO Year
2018
2001

Fundamental Metrics

Financial Performance
Metric
NIO
CORT
Price
$3.67
$113.79
Analyst Decision
Buy
Buy
Analyst Count
10
5
Target Price
$6.73
$96.50
AVG Volume (30 Days)
33.8M
823.3K
Earning Date
06-02-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.09
Revenue
N/A
$761,407,000.00
Revenue This Year
$52.58
$26.08
Revenue Next Year
$18.91
$26.98
P/E Ratio
N/A
$1,224.56
Revenue Growth
N/A
12.79
52 Week Low
$3.55
$28.66
52 Week High
$8.02
$126.38

Technical Indicators

Market Signals
Indicator
NIO
CORT
Relative Strength Index (RSI) 30.10 52.88
Support Level N/A $108.25
Resistance Level $5.22 $124.30
Average True Range (ATR) 0.11 5.29
MACD 0.00 -0.76
Stochastic Oscillator 19.05 61.04

Price Performance

Historical Comparison
NIO
CORT

About NIO NIO Inc. American depositary shares each representing one ordinary share

Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations, such as battery swapping and autonomous driving. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 326,000 EVs in 2025, accounting for about 2% of China's passenger new energy vehicle market.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

Share on Social Networks: